Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma and AIDS.

F M Muggia, M Lonberg

    The Medical Clinics of North America
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Acquired immune deficiency syndrome (AIDS) can cause significant mucocutaneous lesions, including opportunistic infections and Kaposi's sarcoma. This review covers the diagnosis and treatment of these skin conditions in AIDS patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus.

    Gynecologic oncology·2024
    Same author

    BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    Brain metastases from choriocarcinoma: two patients illustrating key management issues.

    Journal of chemotherapy (Florence, Italy)·2008
    Same author

    Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005
    Same author

    Platinums: extending their therapeutic spectrum.

    Journal of chemotherapy (Florence, Italy)·2005
    Same author

    'Retarded pharmaceuticals' assuming a clinical role.

    Onkologie·2004
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Infectious Diseases
    • Immunology

    Background:

    • Mucocutaneous lesions are a common and significant clinical feature in patients with acquired immune deficiency syndrome (AIDS).
    • Individuals with AIDS face increased susceptibility to various opportunistic infections affecting the skin.
    • Aggressive forms of Kaposi's sarcoma frequently manifest in the context of AIDS.

    Purpose of the Study:

    • To discuss the diagnosis of mucocutaneous lesions in AIDS patients.
    • To outline the clinical settings associated with these dermatological manifestations.
    • To review the treatment strategies for opportunistic skin infections and Kaposi's sarcoma in AIDS.

    Main Methods:

    • Literature review of studies on mucocutaneous lesions in AIDS.

    Related Experiment Videos

  • Clinical case analysis of patients with AIDS-related skin conditions.
  • Synthesis of diagnostic criteria and therapeutic approaches.

    • Main Results:

    • Opportunistic infections and Kaposi's sarcoma are key dermatological complications in AIDS.
    • Early and accurate diagnosis is crucial for effective management.
    • Treatment varies depending on the specific lesion and the patient's immune status.

    Conclusions:

    • Management of mucocutaneous lesions in AIDS requires a comprehensive understanding of associated infections and malignancies.
    • Timely intervention improves patient outcomes and quality of life.
    • Ongoing research is vital for advancing treatment protocols for AIDS-related dermatoses.